{
    "Trade/Device Name(s)": [
        "Savanna HSV 1+2/VZV Assay",
        "Savanna HSV 1+2/VZV Control Set",
        "Savanna Instrument"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K232286",
    "Predicate Device Reference 510(k) Number(s)": [
        "K162451"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PGI"
    ],
    "Summary Letter Date": "December 20, 2023",
    "Summary Letter Received Date": "November 21, 2023",
    "Submission Date": "July 31, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.3309"
    ],
    "Regulation Name(s)": [
        "Herpes Virus Nucleic Acid-Based Cutaneous And Mucocutaneous Lesion Panel"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Herpes simplex virus type 1 (HSV-1)",
        "Herpes simplex virus type 2 (HSV-2)",
        "Varicella-zoster virus (VZV)"
    ],
    "Specimen Type(s)": [
        "Cutaneous lesion swab",
        "Mucocutaneous lesion swab"
    ],
    "Specimen Container(s)": [
        "Transport medium (Copan UTM, Remel M4RT, Remel M5, Remel M6)"
    ],
    "Instrument(s)/Platform(s)": [
        "Savanna Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Multiplex PCR",
        "DNA extraction and amplification"
    ],
    "Methodologies": [
        "Qualitative real-time PCR",
        "Nucleic acid detection and differentiation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control Set",
        "Instrument",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Savanna HSV 1+2/VZV Assay, Control Set, and Instrument for qualitative real-time PCR detection of HSV-1, HSV-2, and VZV DNA from lesion swabs.",
    "Indications for Use Summary": "Automated, rapid qualitative real-time PCR assay to detect and differentiate HSV-1, HSV-2, and VZV DNA in cutaneous or mucocutaneous lesion swabs from symptomatic patients suspected of herpes simplex or varicella-zoster infection; aids diagnosis but not for CNS or prenatal screening.",
    "fda_folder": "Microbiology"
}